Literature DB >> 11316065

Early lung leukocyte infiltration, HLA and adhesion molecule expression predict chronic rejection.

G Devouassoux1, C Pison, C Drouet, I Pin, C Brambilla, E Brambilla.   

Abstract

Obliterative bronchiolitis remains the main cause of graft dysfunction and death after 1 year. Defined by an irreversible airway obstruction, bronchiolitis obliterans syndrome is usually recognized in the advanced stage of the disease, with histological evidence of fibrotic damage. Fibrosis represents the end-stage of an inflammatory process, leading to the postulate that chronic lung graft dysfunction is preceded by cellular and molecular events. This study was performed during the first year following lung transplantation, in the absence of histological or functional criteria of chronic rejection. Transbronchial biopsies from eight lung allografts were examined. Four developed a bronchiolitis obliterans syndrome (Group I), and 4 had good outcomes (Group II) at 2 years. Using immunohistochemistry, the aim of the study was to correlate early immunological events with graft outcomes at 2 years. An up-regulation of HLA class I antigen (P = 0.0001), an overexpression of Ki-67 (P = 0.006) on bronchial epithelium, and graft infiltration by CD45+, CD25+ cells (P = 0.003) were significantly associated with the development of chronic rejection. An overexpression of numerous adhesion molecules was observed. However, only very late antigen-4 had a discriminative value (P = 0.04), preceding chronic graft dysfunction. Our results suggest that graft dysfunction is associated with early molecular and cellular events, and raises the possibility that a fibroproliferative disorder is initiated shortly after transplantation. The recognition of such early immunological markers might facilitate improved graft management and prognosis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11316065     DOI: 10.1016/s0966-3274(00)00029-0

Source DB:  PubMed          Journal:  Transpl Immunol        ISSN: 0966-3274            Impact factor:   1.708


  5 in total

1.  Innate immune activation by the viral PAMP poly I:C potentiates pulmonary graft-versus-host disease after allogeneic hematopoietic cell transplant.

Authors:  Christine V Kinnier; Tereza Martinu; Kymberly M Gowdy; Julia L Nugent; Francine L Kelly; Scott M Palmer
Journal:  Transpl Immunol       Date:  2010-11-09       Impact factor: 1.708

2.  IL-12 p80 is an innate epithelial cell effector that mediates chronic allograft dysfunction.

Authors:  Cassandra L Mikols; Le Yan; Jin Y Norris; Tonya D Russell; Anthony P Khalifah; Ramsey R Hachem; Murali M Chakinala; Roger D Yusen; Mario Castro; Elbert Kuo; G Alexander Patterson; Thalachallour Mohanakumar; Elbert P Trulock; Michael J Walter
Journal:  Am J Respir Crit Care Med       Date:  2006-05-25       Impact factor: 21.405

3.  Discovery and Evaluation of Polymorphisms in the AKT2 and AKT3 Promoter Regions for Risk of Korean Lung Cancer.

Authors:  Jae Sook Sung; Kyong Hwa Park; Seung Tae Kim; Yeul Hong Kim
Journal:  Genomics Inform       Date:  2012-09-28

4.  Small interfering RNA efficiently suppresses adhesion molecule expression on pulmonary microvascular endothelium.

Authors:  Tobias Walker; Julian Siegel; Andrea Nolte; Silke Hartmann; Angela Kornberger; Volker Steger; Hans-Peter Wendel
Journal:  J Nucleic Acids       Date:  2011-10-05

Review 5.  Effector immune cells in chronic lung allograft dysfunction: A systematic review.

Authors:  Saskia Bos; Andrew J Filby; Robin Vos; Andrew J Fisher
Journal:  Immunology       Date:  2022-03-01       Impact factor: 7.215

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.